Physician profile
Ryan V V Evans
NPI 1245242981
$1,842.89
in general payments reported to CMS, 2019-2025
18 companies · $459 in 2025
The $459 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $39.04 · 2021: $320 · 2022: $519 · 2023: $42.12 · 2024: $309 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $809.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,065.33 | 2021-2025 | |
| Celgene Corporation | $293.06 | 2021-2023 | Zeposia |
| Amgen INC. | $91.32 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $69.99 | 2022 | |
| Tg Therapeutics, INC. | $40.29 | 2025 | |
| Jazz Pharmaceuticals INC. | $35.15 | 2025 | |
| Axsome Therapeutics, INC. | $32.83 | 2025 | Symbravo |
| Lilly USA, LLC | $27.80 | 2024 | |
| Sunovion Pharmaceuticals INC. | $27.04 | 2020 | |
| Acorda Therapeutics, INC | $22.97 | 2019 | |
| Supernus Pharmaceuticals, INC. | $22.50 | 2019 | |
| Impel Pharmaceuticals INC. | $21.95 | 2022 | |
| Genzyme Corporation | $21.50 | 2025 | |
| Emd Serono, INC. | $18.47 | 2019 | |
| Tonix Medicines, INC. | $15.14 | 2025 | Zembrace Symtouch |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $13.24 | 2022 | |
| Allergan, INC. | $12.31 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $12.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.